F43.10

Post-traumatic stress disorder, unspecified

Post-traumatic stress disorder (PTSD), unspecified (F43.10), is a trauma- and stressor-related disorder that develops in individuals following exposure to an exceptionally threatening or horrific event or series of events. This clinical designation is utilized when the symptomatic profile matches the core diagnostic criteria for PTSD—including intrusion, avoidance, negative alterations in cognition/mood, and hyperarousal—but where the duration (acute vs. chronic) is not specified or information is insufficient to categorize it further. The disorder involves a maladaptive stress response where the individual's psychological and physiological systems remain in a state of high alert long after the threat has passed. To be clinically significant, these symptoms must cause marked distress or functional impairment in social, occupational, or other important areas of life. It is commonly used in initial diagnostic assessments or emergency psychiatric evaluations before a longitudinal history is established.

Clinical Symptoms

  • Recurrent and intrusive distressing memories of the trauma
  • Recurrent distressing dreams or nightmares related to the event
  • Dissociative reactions or flashbacks where the individual feels the trauma is recurring
  • Intense psychological distress upon exposure to internal or external reminders
  • Marked physiological reactions (e.g., racing heart, sweating) to trauma cues
  • Persistent avoidance of distressing memories, thoughts, or feelings about the event
  • Avoidance of external reminders such as people, places, or activities that trigger memories
  • Inability to remember significant aspects of the traumatic event (dissociative amnesia)
  • Persistent and exaggerated negative beliefs about oneself or the world
  • Distorted blame of self or others regarding the causes or consequences of the trauma
  • Persistent negative emotional states such as fear, horror, anger, guilt, or shame
  • Markedly diminished interest in previously enjoyed activities
  • Feelings of detachment or estrangement from others
  • Persistent inability to experience positive emotions like happiness or satisfaction
  • Irritability and aggressive outbursts with little provocation
  • Reckless or self-destructive behavior
  • Hypervigilance and exaggerated startle response
  • Concentration difficulties and sleep disturbances

Common Causes

  • Exposure to actual or threatened death, serious injury, or sexual violence
  • Direct experience of a traumatic event (e.g., combat, physical assault, disaster)
  • Witnessing a traumatic event occurring to others in person
  • Learning that a traumatic event occurred to a close family member or friend
  • Experiencing repeated or extreme exposure to aversive details of traumatic events (e.g., first responders)
  • Pre-existing mental health conditions such as anxiety or depression
  • Lack of a strong social support system following the trauma
  • Biological vulnerability including dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis
  • Structural and functional changes in brain regions such as the amygdala, hippocampus, and prefrontal cortex

Documentation & Coding Tips

Distinguish between Acute and Chronic PTSD when possible to avoid the unspecified code.

Example: Patient presents with persistent intrusive memories and avoidance behaviors following a motor vehicle accident 4 months ago. While symptoms meet DSM-5 criteria, the clinical record currently lacks the specific 6-month threshold required for the chronic designation. Diagnosed with PTSD, unspecified (F43.10) pending further longitudinal assessment. Plan: Sertraline titration and referral for trauma-focused CBT. This condition is an active problem contributing to the current treatment plan and maps to HCC 155.

Billing Focus: Documentation should reflect the clinical rationale for using an unspecified code, such as insufficient duration or incomplete historical data at the initial visit.

Clearly document the traumatic event and the specific clusters of symptoms present.

Example: Patient reports recurrent distressing dreams and physiological reactivity to cues reminding them of a physical assault. Demonstrates marked hypervigilance and exaggerated startle response. Symptoms have caused significant distress in social functioning. Current status: PTSD, unspecified (F43.10). Comorbidities include Type 2 Diabetes (E11.9) which complicates treatment due to cortisol-related glucose fluctuations. Plan: Initiate Prazosin 1mg at bedtime for nightmares.

Billing Focus: Include specific symptom clusters such as intrusion, avoidance, and alterations in arousal to support the medical necessity of psychiatric diagnostic evaluations (90791).

Document functional impairment and the necessity for specific therapeutic interventions.

Example: Established patient with PTSD, unspecified (F43.10) showing persistent inability to maintain employment due to dissociative flashbacks. MDM is Moderate due to the risk of self-harm and the need for medication management involving SSRIs. Session duration: 35 minutes of face-to-face time. Patient stable on current regimen but requires continued monthly monitoring. This chronic mental health condition requires ongoing management to prevent relapse.

Billing Focus: For E/M code 99214, documentation must support Moderate MDM or 30-39 minutes of total time spent on the date of the encounter.

Identify and document any co-occurring substance use disorders.

Example: Patient with PTSD, unspecified (F43.10) currently using Alcohol (F10.10) as a maladaptive coping mechanism for sleep-onset insomnia and intrusive thoughts. The interaction between PTSD symptoms and substance use increases the complexity of care. We discussed the impact of alcohol on REM sleep and PTSD recovery. Treatment involves integrated dual-diagnosis approach. Risk remains Moderate given the patient's history of impulsive behaviors when triggered.

Billing Focus: Ensure that both the PTSD and the substance use disorder are coded to capture the full scope of the patient's clinical complexity.

Regularly update the documentation to reflect changes in symptom severity and treatment response.

Example: Annual review of patient with PTSD, unspecified (F43.10). The patient has shown a 30 percent reduction in PCL-5 scores following 12 sessions of EMDR. However, hyperarousal remains a significant barrier to nighttime rest. Continuing current dose of Paroxetine. The condition remains active and requires continued specialty care. No suicidal ideation reported today. Risk assessment: Moderate due to chronic psychiatric morbidity.

Billing Focus: Use standardized assessment tools (like PCL-5) in documentation to provide objective evidence of the condition's severity and the effectiveness of the treatment plan.

Relevant CPT Codes

Related Diagnoses

Hierarchy